Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2014 1
2015 2
2016 2
2017 2
2018 3
2019 1
2020 3
2021 9
2022 18
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2.
Majdoubi A, Michalski C, O'Connell SE, Dada S, Narpala S, Gelinas J, Mehta D, Cheung C, Winkler DF, Basappa M, Liu AC, Görges M, Barakauskas VE, Irvine M, Mehalko J, Esposito D, Sekirov I, Jassem AN, Goldfarb DM, Pelech S, Douek DC, McDermott AB, Lavoie PM. Majdoubi A, et al. Among authors: jassem an. JCI Insight. 2021 Apr 22;6(8):e146316. doi: 10.1172/jci.insight.146316. JCI Insight. 2021. PMID: 33720905 Free PMC article.
Measles Lymphadenopathy in a Child With PFAPA Syndrome.
Terry J, Brown K, Hiebert J, Al-Rawahi GN, Moxham JP, Krajden M, Jassem AN, Tucker L. Terry J, et al. Among authors: jassem an. Pediatr Dev Pathol. 2018 Sep-Oct;21(5):497-501. doi: 10.1177/1093526617727970. Epub 2017 Sep 7. Pediatr Dev Pathol. 2018. PMID: 28882091
Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.
Hogan CA, Jassem AN, Sbihi H, Joffres Y, Tyson JR, Noftall K, Taylor M, Lee T, Fjell C, Wilmer A, Galbraith J, Romney MG, Henry B, Krajden M, Galanis E, Prystajecky N, Hoang LMN. Hogan CA, et al. Among authors: jassem an. Emerg Infect Dis. 2021 Nov;27(11):2802-2809. doi: 10.3201/eid2711.211190. Epub 2021 Aug 13. Emerg Infect Dis. 2021. PMID: 34388358 Free PMC article.
COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report.
Leung WF, Chorlton S, Tyson J, Al-Rawahi GN, Jassem AN, Prystajecky N, Masud S, Deans GD, Chapman MG, Mirzanejad Y, Murray MCM, Wong PHP. Leung WF, et al. Among authors: jassem an. Int J Infect Dis. 2022 Jan;114:178-182. doi: 10.1016/j.ijid.2021.10.045. Epub 2021 Oct 29. Int J Infect Dis. 2022. PMID: 34757008 Free PMC article.
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O'Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM. Grunau B, et al. Among authors: jassem an. Clin Infect Dis. 2022 Aug 24;75(1):e888-e891. doi: 10.1093/cid/ciab938. Clin Infect Dis. 2022. PMID: 34849655 Free PMC article.
Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity.
Asamoah-Boaheng M, Goldfarb D, Prusinkiewicz MA, Golding L, Karim ME, Barakauskas V, Wall N, Jassem AN, Marquez AC, MacDonald C, O'Brien SF, Lavoie P, Grunau B. Asamoah-Boaheng M, et al. Among authors: jassem an. Cureus. 2023 Jan 31;15(1):e34465. doi: 10.7759/cureus.34465. eCollection 2023 Jan. Cureus. 2023. PMID: 36874687 Free PMC article.
40 results